Auf dieser Seite
COGT Cogent Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 5, 2026 10-K/10-Q Aug 10, 2026
$30,66
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$13,7852-Wochen-Tief
$43,7352-Wochen-Hoch
Marktkapitalisierung (MRQ)
$5.26B
P/E
-14.2
EPS
$-2.16
Ihre Abzeichen
52W-Spanne
$14–$44
Analystenbewertung
STRONG BUY
Kursziel
$56
P/E
-14.2
ROE
-83.1%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
COGT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$30.66
Marktkapitalisierung (MRQ)
$5.26B
P/E
-14.2
EPS
$-2.16
ROE
-83.1%
52W-Spanne
$14–$44
COGT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 9. November 2020 | 1-for-4 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz·2017-12-31 → 2020-12-31
EPS$-2.162021-12-31 → 2025-12-31
Freier Cashflow$-266M2018-12-31 → 2025-12-31
Nettogewinnmarge·2018-12-31 → 2020-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | COGT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -14.25-Jahres-Durchschnitt ≈-7.0 | ≈-7.0 | · | · | |
| P/S | 213.15-Jahres-Durchschnitt ≈71.4 | ≈71.4 | 60.4 | Überbewertet | |
| K/B (MRQ) | 9.95-Jahres-Durchschnitt ≈3.8 | ≈3.8 | 9.3 | Teurer | |
| Kurs / FCF (TTM) | -17.05-Jahres-Durchschnitt ≈-8.3 | ≈-8.3 | · | · | |
| Kurs / Cashflow (TTM) | -17.15-Jahres-Durchschnitt ≈-8.5 | ≈-8.5 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 7.85-Jahres-Durchschnitt ≈3.8 | ≈3.8 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | COGT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -52.0%5-Jahres-Durchschnitt ≈-55.4% | ≈-55.4% | -22.3% | Schwach | |
| ROE | -83.1%5-Jahres-Durchschnitt ≈-65.6% | ≈-65.6% | -35.2% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | COGT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 13.65-Jahres-Durchschnitt ≈9.9 | ≈9.9 | 9.6 | Starke Liquidität | |
| Quick Ratio | 4.95-Jahres-Durchschnitt ≈5.2 | ≈5.2 | 5.0 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
2.0%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 11, 2026 | $-0.52 | $-0.58 | 10.5% |
| 31. März 2026 | Mai 12, 2026 | $-0.60 | $-0.55 | -8.8% |
| 31. Dezember 2025 | $-0.64 | $-0.53 | -20.9% | |
| 30. September 2025 | $-0.50 | $-0.54 | 7.1% | |
| 30. Juni 2025 | $-0.53 | $-0.60 | 11.4% | |
| 31. März 2025 | $-0.52 | $-0.60 | 12.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $8M | $22M | $10M | $8M | |
| R&D Expense | $270M | $233M | $174M | $122M | $56M | $26M | $44M | $38M | $30M | |
| SG&A Expense | $64M | $43M | $34M | $26M | $20M | $17M | $11M | $7M | $5M | |
| Operating Expenses | $333M | $276M | $208M | $148M | $76M | $90M | $55M | $46M | $35M | |
| Operating Income | $-333M | $-276M | $-208M | $-148M | $-76M | $-82M | $-32M | $-36M | $-26M | |
| Interest Income | $15M | $18M | $13M | $4M | $467.0K | $144.0K | $267.0K | $1M | $386.0K | |
| Other Non-op | $-20.0K | $2M | $943.0K | $2M | $3M | $7M | $345.0K | $320.0K | $274.0K | |
| Income Tax | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-329M | $-256M | $-192M | $-140M | $-72M | $-75M | $-32M | $-35M | $-25M | |
| EPS (Basic) | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 | · | · | · | · | |
| EPS (Diluted) | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 | · | · | · | · | |
| Shares (Basic) | 128,899,408 | 103,856,611 | 79,657,942 | 58,739,713 | 38,730,813 | · | · | · | · | |
| Shares (Diluted) | 128,899,408 | 103,856,611 | 79,657,942 | 58,739,713 | 38,730,813 | · | · | · | · | |
| EBITDA | $-333M | $-276M | $-208M | $-148M | $-76M | $-82M | $-32M | $-36M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $312M | $98M | $53M | $140M | $220M | $242M | $37M | $56M | $28M | |
| Short-term Investments | · | · | · | · | · | · | · | $23M | $13M | |
| Receivables | · | · | · | · | · | · | $2M | $2M | $830.0K | |
| Prepaid Expense | $10M | $9M | $5M | $4M | $3M | $3M | $1M | $740.0K | $513.0K | |
| Current Assets | $910M | $296M | $271M | $265M | $223M | $245M | $41M | $81M | $42M | |
| PP&E (Net) | $5M | $6M | $8M | $8M | $2M | $134.0K | $2M | $3M | $4M | |
| PP&E (Gross) | $14M | $13M | $12M | $9M | $2M | $546.0K | $6M | $7M | $6M | |
| Accum. Depreciation | $9M | $6M | $4M | $1M | $559.0K | $412.0K | $5M | $3M | $2M | |
| Other Non-current Assets | $3M | $5M | $5M | $5M | $4M | · | $427.0K | $419.0K | · | |
| Total Assets | $938M | $328M | $313M | $301M | $232M | $251M | $49M | $86M | $49M | |
| Accounts Payable | $10M | $12M | $11M | $6M | $3M | $732.0K | $3M | $2M | $1M | |
| Current Liabilities | $64M | $56M | $38M | $27M | $17M | $13M | $13M | $25M | $11M | |
| Capital Leases | $14M | $16M | $17M | $18M | $831.0K | $3M | $4M | · | · | |
| Other Non-current Liabilities | $33.0K | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $301M | $72M | $56M | $45M | $18M | $16M | $18M | $26M | $21M | |
| Long-term Debt | $223M | · | · | · | · | · | · | · | · | |
| Common Stock | $161.0K | $110.0K | $86.0K | $70.0K | $44.0K | $32.0K | $8.0K | $30.0K | $10.0K | |
| Retained Earnings | $-1.19B | $-859M | $-604M | $-411M | $-271M | $-199M | $-124M | $-92M | $-51M | |
| AOCI | $355.0K | $447.0K | $246.0K | $-104.0K | · | · | · | $-12.0K | $-16.0K | |
| Stockholders' Equity | $636M | $256M | $258M | $256M | $214M | $235M | $32M | $60M | $-49M | |
| Liabilities + Equity | $938M | $328M | $313M | $301M | $232M | $251M | $49M | $86M | $49M | |
| Shares Outstanding | 160,980,024 | 110,461,729 | 86,124,249 | 69,893,434 | 43,805,922 | 32,347,905 | 7,665,763 | 30,057,970 | 10,201,690 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $2M | $2M | $800.0K | $147.0K | $720.0K | $1M | $1M | $1M | |
| Stock-based Comp | $46M | $40M | $31M | $18M | $12M | $6M | $3M | $3M | $1M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | · | · | · | $4M | · | · | · | |
| Operating Cash Flow | $-264M | $-208M | $-154M | $-119M | $-59M | $-36M | $-42M | $-32M | $-26M | |
| CapEx | $2M | $573.0K | $3M | $7M | $2M | · | $33.0K | $549.0K | $912.0K | |
| Investing Cash Flow | $-400M | $38M | $-98M | $-125M | $-2M | $8M | $23M | $-11M | $14M | |
| Debt Issued | $49M | $0 | $0 | · | · | · | · | · | · | |
| Net Debt Issued | $49M | · | · | · | · | · | · | · | · | |
| Stock Issued | · | $0 | $162M | $0 | $0 | $25M | $108.0K | $609.0K | $60.0K | |
| Net Stock Activity | · | $0 | $162M | · | · | $25M | $108.0K | $609.0K | · | |
| Financing Cash Flow | $878M | $214M | $164M | $164M | $38M | $232M | $108.0K | $70M | $-729.0K | |
| Net Change in Cash | $214M | $45M | $-88M | $-80M | $-23M | $205M | $-18M | $27M | $-13M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-266M | $-208M | $-156M | $-126M | $-60M | · | $-42M | $-33M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -1044.3% | -143.0% | -369.9% | · | |
| Net Margin | · | · | · | · | · | -950.4% | -141.5% | -354.8% | · | |
| EBITDA Margin | · | · | · | · | · | -1044.3% | -143.0% | -369.9% | · | |
| ROA | -52.0% | -79.8% | -62.6% | -52.6% | -29.9% | -49.8% | -47.0% | -51.1% | · | |
| ROE | -83.1% | -89.6% | -68.6% | -51.4% | -35.1% | -70.4% | -105.4% | -54.1% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.2 | 5.3 | 7.1 | 9.9 | 13.0 | 18.7 | 3.1 | 3.2 | · | |
| Quick Ratio | 4.9 | 1.8 | 1.4 | 5.2 | 12.9 | 18.5 | 3.0 | 3.2 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.1 | 0.3 | 0.1 | · | |
| Receivables Turnover | · | · | · | · | · | · | 12.3 | 7.8 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.95 | $2.32 | $2.99 | $3.66 | $4.89 | $7.25 | $1.04 | $2.00 | · | |
| Cash Flow / Share | $-2.05 | $-2.00 | $-1.93 | $-2.02 | · | · | · | · | · | |
| Cash / Share | $1.94 | $0.89 | $0.62 | $2.00 | $5.01 | $7.49 | $1.22 | $1.85 | · | |
| EPS (TTM) | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 | $-1.05 | $-1.05 | $-1.60 | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $23M | $23M | $23M | $23M | $23M | $8M | $22M | $10M | · | |
| Net Income TTM | $-329M | $-256M | $-192M | $-140M | $-72M | $-75M | $-32M | $-35M | · | |
| Market Cap | $5.72B | $862M | $506M | $808M | $376M | $363M | $88M | $529M | · | |
| P/E | -16.4 | -4.0 | -3.0 | -6.7 | -4.6 | -10.7 | -2.7 | -11.0 | · | |
| P/S | 246.9 | 37.2 | 21.9 | 34.9 | 16.2 | 46.2 | 3.9 | 54.3 | · | |
| P/B | 9.0 | 3.4 | 2.0 | 3.2 | 1.8 | 1.5 | 2.8 | 8.8 | · | |
| P / Tangible Book | 9.0 | 3.4 | 2.0 | 3.2 | 1.8 | 1.5 | · | · | · | |
| P / Cash Flow | -21.6 | -4.1 | -3.3 | -6.8 | -6.4 | -10.1 | -2.1 | -16.3 | · | |
| P / FCF | -21.5 | -4.1 | -3.2 | -6.4 | -6.2 | · | -2.1 | -16.0 | · | |
| Earnings Yield | -6.1% | -24.9% | -33.0% | -15.0% | -21.8% | -9.3% | -36.5% | -9.1% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $71M | $75M | $76M | $69M | $62M | $63M | $62M | $64M | $54M | $53M | $50M | $39M | $36M | $30M | $29M | $25M | |
| SG&A Expense | $32M | $28M | $24M | $14M | $13M | $12M | $12M | $12M | $10M | $10M | $9M | $8M | $7M | $7M | $6M | $6M | |
| Operating Expenses | $103M | $104M | $99M | $83M | $76M | $75M | $74M | $75M | $64M | $62M | $60M | $47M | $43M | $37M | $36M | $31M | |
| Operating Income | $-103M | $-104M | $-99M | $-83M | $-76M | $-75M | $-74M | $-75M | $-64M | $-62M | $-60M | $-47M | $-43M | $-37M | $-36M | $-31M | |
| Interest Income | $7M | $8M | $5M | $4M | $2M | $3M | $4M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $272.0K | $107.0K | |
| Other Non-op | $-11.0K | $-140.0K | $-6.0K | $-3.0K | $-6.0K | $-5.0K | $2M | $1.0K | $44.0K | $-1.0K | $0 | $268.0K | $682.0K | $2M | $928.0K | $784.0K | |
| Net Income | $-96M | $-97M | $-102M | $-81M | $-74M | $-72M | $-68M | $-71M | $-59M | $-58M | $-55M | $-44M | $-39M | $-35M | $-35M | $-31M | |
| EPS (Basic) | $-0.52 | $-0.53 | $-0.61 | $-0.50 | $-0.53 | $-0.52 | $-0.50 | $-0.52 | $-0.43 | $-0.49 | $-0.64 | $-0.59 | $-0.55 | $-0.50 | $-0.71 | $-0.68 | |
| EPS (Diluted) | $-0.52 | $-0.53 | $-0.61 | $-0.50 | $-0.53 | $-0.52 | $-0.50 | $-0.52 | $-0.43 | $-0.49 | $-0.64 | $-0.59 | $-0.55 | $-0.50 | $-0.71 | $-0.68 | |
| Shares (Basic) | 171,005,468 | 162,194,778 | · | 137,550,159 | 114,466,080 | 113,307,940 | · | 110,165,580 | 99,240,030 | 94,804,659 | 86,165,951 | 74,753,269 | 70,734,950 | 69,576,359 | 49,388,936 | 45,105,923 | |
| Shares (Diluted) | 171,005,468 | 162,194,778 | · | 137,550,159 | 114,466,080 | 113,307,940 | · | 110,165,580 | 99,240,030 | 94,804,659 | 86,165,951 | 74,753,269 | 70,734,950 | 69,576,359 | 49,388,936 | 45,105,923 | |
| EBITDA | $-103M | $-104M | · | $-83M | $-76M | $-75M | · | $-75M | $-64M | $-62M | $-60M | $-47M | $-43M | $-37M | $-36M | $-31M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $181M | $241M | $312M | $125M | $128M | $126M | $98M | $97M | $88M | $216M | $87M | $214M | $161M | $141M | $326M | $191M | |
| Prepaid Expense | $13M | $11M | $10M | $6M | $7M | $7M | $9M | $6M | $7M | $6M | $7M | $5M | $5M | $6M | $4M | $4M | |
| Current Assets | $805M | $878M | $910M | $397M | $245M | $253M | $296M | $342M | $370M | $442M | $286M | $335M | $226M | $296M | $331M | $195M | |
| PP&E (Net) | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $8M | $9M | $9M | $9M | $7M | $4M | $2M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $13M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $9M | · | · | · | $6M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $3M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Total Assets | $835M | $903M | $938M | $426M | $275M | $284M | $328M | $384M | $430M | $476M | $355M | $392M | $263M | $332M | $366M | $207M | |
| Accounts Payable | $7M | $14M | $10M | $16M | $17M | $14M | $12M | $15M | $9M | $16M | $10M | $7M | $4M | $4M | $3M | $4M | |
| Current Liabilities | $59M | $58M | $64M | $62M | $58M | $49M | $56M | $53M | $40M | $37M | $35M | $26M | $21M | $24M | $28M | $18M | |
| Capital Leases | $19M | $14M | $14M | $15M | $15M | $15M | $16M | $16M | $17M | $17M | $18M | $18M | $19M | $18M | $19M | $1M | |
| Other Non-current Liabilities | $90.0K | $62.0K | $33.0K | $2M | $2M | $5.0K | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $302M | $295M | $301M | $123M | $120M | $65M | $72M | $69M | $57M | $54M | $53M | $44M | $40M | $42M | $47M | $19M | |
| Long-term Debt | $223M | $223M | $223M | $44M | $44M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | $44M | $44M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $171.0K | $171.0K | $161.0K | $141.0K | $114.0K | $114.0K | $110.0K | $110.0K | $109.0K | $96.0K | $86.0K | $85.0K | $71.0K | $70.0K | $66.0K | $46.0K | |
| Retained Earnings | $-1.38B | $-1.29B | $-1.19B | $-1.09B | $-1.00B | $-931M | $-859M | $-792M | $-721M | $-662M | $-549M | $-494M | $-450M | $-372M | $-337M | $-302M | |
| AOCI | $-770.0K | $-415.0K | $355.0K | $208.0K | $13.0K | $164.0K | $447.0K | $896.0K | $-192.0K | $-39.0K | $-172.0K | $-97.0K | $16.0K | $-163.0K | · | · | |
| Stockholders' Equity | $532M | $608M | $636M | $302M | $155M | $219M | $256M | $315M | $373M | $422M | $303M | $348M | $224M | $290M | $319M | $188M | |
| Liabilities + Equity | $835M | $903M | $938M | $426M | $275M | $284M | $328M | $384M | $430M | $476M | $355M | $392M | $263M | $332M | $366M | $207M | |
| Shares Outstanding | 171,598,409 | 170,773,803 | 160,980,024 | 139,827,662 | 113,928,492 | 113,856,454 | 110,461,729 | 110,458,249 | 109,343,224 | 95,613,396 | 86,124,249 | 85,334,165 | 70,946,790 | 69,857,972 | 65,707,714 | 45,819,266 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $741.0K | $626.0K | $664.0K | $641.0K | $655.0K | $640.0K | $675.0K | $620.0K | $606.0K | $599.0K | $581.0K | $562.0K | $529.0K | $256.0K | $97.0K | $69.0K | |
| Stock-based Comp | $17M | $17M | $16M | $11M | $10M | $10M | $10M | $10M | $10M | $9M | $9M | $7M | $6M | $5M | $5M | $4M | |
| Operating Cash Flow | $-77M | $-87M | $-79M | $-64M | $-55M | $-67M | $-61M | $-52M | $-43M | $-53M | $-38M | $-32M | $-40M | $-34M | $-26M | $-28M | |
| CapEx | $370.0K | $449.0K | $811.0K | $65.0K | $131.0K | $547.0K | $75.0K | $280.0K | $148.0K | $70.0K | $121.0K | $1M | $1M | $3M | $1M | $441.0K | |
| Investing Cash Flow | $14M | $-36M | $-323M | $-155M | $9M | $69M | $62M | $60M | $-85M | $1M | $-91M | $-78M | $60M | $-152M | $-1M | $-441.0K | |
| Debt Issued | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $0 | · | · | $-170.0K | · | · | · | · | · | |
| Financing Cash Flow | $3M | $53M | $589M | $217M | $47M | $25M | $26.0K | $624.0K | $-256.0K | $214M | $1M | $162M | $445.0K | $990.0K | $162M | $138.0K | |
| Net Change in Cash | $-60M | $-71M | $187M | $-2M | $2M | $28M | $1M | $9M | $-128M | $163M | $-128M | $52M | $21M | $-185M | $135M | $-29M | |
| Free Cash Flow | · | $-87M | · | · | · | $-67M | · | · | · | $-53M | · | · | $-41M | · | · | $-29M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -17.4% | -16.4% | · | -20.0% | -20.9% | -18.9% | · | -19.1% | -14.3% | -15.8% | -16.1% | -11.6% | -16.4% | -12.8% | -11.8% | -13.8% | |
| ROE | -28.1% | -23.5% | · | -26.2% | -27.8% | -22.4% | · | -22.9% | -16.3% | -18.1% | -18.7% | -13.2% | -18.8% | -14.4% | -13.1% | -14.8% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.6 | 15.1 | · | 6.4 | 4.2 | 5.1 | · | 6.4 | 9.2 | 12.0 | 8.2 | 13.0 | 10.7 | 12.6 | 12.0 | 10.9 | |
| Quick Ratio | 3.1 | 4.2 | · | 2.0 | 2.2 | 2.6 | · | 1.8 | 2.2 | 5.9 | 2.5 | 8.3 | 7.6 | 6.0 | 11.8 | 10.7 | |
| Debt / Equity | · | · | · | 0.1 | 0.3 | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.1 | 0.3 | · | · | · | · | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.10 | $3.56 | · | $2.16 | $1.36 | $1.92 | · | $2.85 | $3.41 | $4.42 | $3.52 | $4.08 | $3.15 | $4.15 | $4.86 | $4.10 | |
| Cash Flow / Share | · | $-0.54 | · | · | · | $-0.59 | · | · | · | $-0.55 | · | · | $-0.56 | · | · | · | |
| Cash / Share | $1.06 | $1.41 | · | $0.90 | $1.12 | $1.11 | · | $0.88 | $0.81 | $2.26 | $1.01 | $2.51 | $2.27 | $2.01 | $4.95 | $4.17 | |
| EPS (TTM) | $-2.16 | $-2.17 | · | $-2.05 | $-2.07 | $-1.97 | · | $-1.60 | $-1.72 | $-1.88 | $-1.62 | $-1.48 | $-1.60 | $-2.51 | $-2.49 | $-2.21 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $8M | · | $8M | $8M | $8M | · | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Net Income TTM | $-377M | $-354M | · | $-294M | $-284M | $-269M | · | $-242M | $-227M | $-212M | $-178M | $-157M | $-148M | $-126M | $-110M | $-91M | |
| Market Cap | $6.64B | $6.57B | · | $2.01B | $818M | $682M | · | $1.19B | $922M | $643M | $840M | $1.01B | $766M | $1.04B | $593M | $343M | |
| Enterprise Value | · | · | · | $1.93B | $734M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -17.9 | -17.7 | · | -7.0 | -3.5 | -3.0 | · | -6.8 | -4.9 | -3.6 | -6.0 | -8.0 | -6.7 | -5.9 | -3.6 | -3.4 | |
| P/S | 843.7 | 835.1 | · | 255.1 | 103.9 | 86.6 | · | 151.6 | 117.1 | 81.6 | 106.7 | 128.4 | 97.3 | 132.4 | 75.3 | 43.6 | |
| P/B | 12.5 | 10.8 | · | 6.6 | 5.3 | 3.1 | · | 3.8 | 2.5 | 1.5 | 2.8 | 2.9 | 3.4 | 3.6 | 1.9 | 1.8 | |
| P / Tangible Book | 12.5 | 10.8 | · | 6.6 | 5.3 | 3.1 | · | 3.8 | 2.5 | 1.5 | 2.8 | 2.9 | 3.4 | 3.6 | 1.9 | 1.8 | |
| P / Cash Flow | · | -75.7 | · | · | · | -10.3 | · | · | · | -12.2 | · | · | -19.4 | · | · | -12.1 | |
| EV / Revenue | · | · | · | 244.8 | 93.3 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -5.6% | -5.6% | · | -14.3% | -28.8% | -32.9% | · | -14.8% | -20.4% | -28.0% | -16.6% | -12.5% | -14.8% | -16.8% | -27.6% | -29.5% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-329M | $-256M | $-192M | $-140M | $-72M |
| Verwässerte EPS | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 14.2 | 5.3 | 7.1 | 9.9 | 13.0 |
| Quick Ratio | 4.9 | 1.8 | 1.4 | 5.2 | 12.9 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-266M | $-208M | $-156M | $-126M | $-60M |
Institutionelle Eigentümer (13F) 340 Einreicher · $7.6B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
340
Gehaltener Wert
$7.6B
Neue Positionen
65
Geschlossene Positionen
41
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 65 (-17 vs. Vorquartal) | 41 (+7 vs. Vorquartal) | 133 (+15 vs. Vorquartal) | 90 (+9 vs. Vorquartal) | +3.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $993.861.419 | 25.681.174 | 13,11% | Aktien |
| BlackRock, Inc. | $671.547.401 | 17.352.646 | 8,86% | Aktien |
| VANGUARD GROUP INC | $408.988.860 | 11.514.326 | 5,40% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $312.402.306 | 8.072.411 | 4,12% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $286.857.171 | 7.412.330 | 3,78% | Aktien |
| STATE STREET CORP | $269.542.365 | 6.964.919 | 3,56% | Aktien |
| JANUS HENDERSON GROUP PLC | $229.633.788 | 5.965.125 | 3,03% | Aktien |
| Fairmount Funds Management LLC | $212.982.277 | 5.503.418 | 2,81% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $193.736.225 | 5.006.104 | 2,56% | Aktien |
| TCG Crossover Management, LLC | $187.866.673 | 4.854.436 | 2,48% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $174.534.880 | 4.508.998 | 2,30% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $168.111.910 | 4.343.977 | 2,22% | Aktien |
| Kynam Capital Management, LP | $141.916.654 | 3.667.097 | 1,87% | Aktien |
| Polar Capital Holdings Plc | $125.113.424 | 3.232.905 | 1,65% | Aktien |
| Commodore Capital LP | $118.035.000 | 3.050.000 | 1,56% | Aktien |
| Invesco Ltd. | $100.973.759 | 2.609.141 | 1,33% | Aktien |
| Woodline Partners LP | $100.742.369 | 2.603.162 | 1,33% | Aktien |
| Pictet Asset Management Holding SA | $92.634.023 | 2.393.515 | 1,22% | Aktien |
| Octagon Capital Advisors LP | $90.945.000 | 2.350.000 | 1,20% | Aktien |
| RTW INVESTMENTS, LP | $89.359.113 | 2.309.021 | 1,18% | Aktien |
| GOLDMAN SACHS GROUP INC | $88.570.098 | 2.288.633 | 1,17% | Aktien |
| Candriam S.C.A. | $80.742.121 | 2.088.369 | 1,07% | Aktien |
| Deep Track Capital, LP | $77.400.000 | 2.000.000 | 1,02% | Aktien |
| Siren, L.L.C. | $71.954.097 | 1.859.279 | 0,95% | Aktien |
| ORBIMED ADVISORS LLC | $65.066.310 | 1.681.300 | 0,86% | Aktien |
| Venrock Adviser, LLC | $63.551.824 | 1.642.166 | 0,84% | Aktien |
| EMERALD ADVISERS, LLC | $62.048.445 | 1.603.319 | 0,82% | Aktien |
| NORTHERN TRUST CORP | $60.288.021 | 1.557.830 | 0,80% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $56.087.910 | 1.449.300 | 0,74% | Aktien |
| Assenagon Asset Management S.A. | $55.795.957 | 1.441.756 | 0,74% | Aktien |
| BANK OF AMERICA CORP /DE/ | $55.713.759 | 1.439.632 | 0,74% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $55.455.537 | 1.432.957 | 0,73% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $49.563.361 | 1.280.707 | 0,65% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $46.962.837 | 1.213.510 | 0,62% | Aktien |
| Elmind Capital, LP | $45.307.638 | 1.170.740 | 0,60% | Aktien |
| UBS Group AG | $43.430.881 | 1.122.245 | 0,57% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $41.518.521 | 1.072.830 | 0,55% | Aktien |
| Sofinnova Investments, Inc. | $40.060.228 | 1.035.148 | 0,53% | Aktien |
| EMERALD MUTUAL FUND ADVISERS TRUST | $39.914.329 | 1.031.378 | 0,53% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $39.558.482 | 1.022.183 | 0,52% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $38.551.702 | 996.168 | 0,51% | Aktien |
| Balyasny Asset Management L.P. | $36.952.424 | 954.843 | 0,49% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $36.871.696 | 952.757 | 0,49% | Aktien |
| MORGAN STANLEY | $36.444.817 | 941.725 | 0,48% | Aktien |
| D. E. Shaw & Co., Inc. | $35.699.937 | 922.479 | 0,47% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $35.128.454 | 907.712 | 0,46% | Aktien |
| Logos Global Management LP | $34.830.000 | 900.000 | 0,46% | Aktien |
| Squadron Capital Management LLC | $33.475.500 | 865.000 | 0,44% | Aktien |
| CITADEL ADVISORS LLC | $32.883.158 | 849.694 | 0,43% | Aktien |
| Point72 Asset Management, L.P. | $28.800.347 | 744.195 | 0,38% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II GP LLC ×11 Einreichungen | 31. März 2026 | 8,60% | Änderung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 25 Insider · 11 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Andrew R Robbins | President and CEO | 19. Mai 2026 G | 160.000 | 0 | 0 | $0 |
| Charles Wilson | Chief Executive Officer | 1. März 2019 A | · | 0 | 0 | $0 |
| John L. Green | Chief Financial Officer | 26. Dezember 2025 S | 131.834 | 0 | 1 | $-2.978.360 |
| Matthew Scott Osborne | Chief Financial Officer | 11. Februar 2020 A | · | 0 | 0 | $0 |
| John Edward Robinson | Chief Scientific Officer | 26. Dezember 2025 S | 140.002 | 0 | 1 | $-3.486.600 |
| Jessica Sachs | Chief Medical Officer | 26. Dezember 2025 S | 133.938 | 0 | 1 | $-3.198.245 |
| Evan Kearns | Chief Legal Officer | 26. Dezember 2025 S | 109.398 | 0 | 1 | $-2.515.500 |
| Cole Pinnow | Chief Commercial Officer | 17. Dezember 2025 A | 216.650 | 0 | 0 | $0 |
| Geoffrey Hodge | Chief Technical Officer | 11. Februar 2020 A | · | 0 | 0 | $0 |
| Seth Ettenberg | Chief Scientific Officer | 11. Februar 2020 A | 0 | 0 | 0 | $0 |
| Michael Vasconcelles | Chief Medical Officer | 1. März 2019 A | · | 0 | 0 | $0 |
| Arlene Morris | Direktor | 27. August 2026 M | 0 | 0 | 2 | $-1.689.388 |
| Karen Jean Ferrante | Direktor | 1. Juli 2026 A | · | 0 | 0 | $0 |
| Christopher W. Cain | Direktor | 9. Juni 2026 A | · | 0 | 0 | $0 |
| Todd Shegog | Direktor | 9. Juni 2026 A | · | 0 | 0 | $0 |
| Matthew Ros | Direktor | 9. Juni 2026 A | · | 0 | 0 | $0 |
| Peter Harwin | Direktor | 9. Juni 2026 A | · | 0 | 0 | $0 |
| Fairmount Funds Management LLC | Direktor | 31. März 2026 C | 5.503.418 | 0 | 2 | $-370.020.000 |
| Jorn Aldag | Direktor | 1. Juli 2020 A | · | 0 | 0 | $0 |
| Bruce Booth | Direktor | 1. Juli 2020 A | 3.361.535 | 0 | 0 | $0 |
| Liam Ratcliffe | Direktor | 14. Juni 2019 A | 897.773 | 0 | 0 | $0 |
| Robert J Perez | Direktor | 14. Juni 2019 A | · | 0 | 0 | $0 |
| Dario Campana | 10%-Eigentümer | 12. Mai 2020 S | 3.095.114 | 0 | 0 | $0 |
| FIL Ltd | · | 3. April 2018 C | 1.138.274 | 0 | 0 | $0 |
| FMR LLC | · | 3. April 2018 C | 23.240 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 35 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| LABU · Direxion Shares ETF Trust | 0,85% | 107.533 NS | 31. Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,79% | 9.390 NS | 31. Juli 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,62% | 57.786 NS | 31. Juli 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0,58% | 134.513 NS | 31. Juli 2026 | N-PORT |
| ESSC · Strategy Shares | 0,44% | 4.046 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,38% | 178.467 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,37% | 1.569.593 SH | 11. September 2026 | Täglich |
| IBB · iShares Trust | 0,37% | 1.125.962 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,37% | 12.272 SH | 2. Oktober 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,25% | 95.539 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,24% | 1.469 NS | 31. Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 42.273 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,21% | 79.831 NS | 31. Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,20% | 4.588 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,20% | 959.613 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,19% | 4.260.580 SH | 11. September 2026 | Täglich |
| ISCG · iShares Trust | 0,17% | 49.190 SH | 11. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,17% | 85.339 SH | 19. August 2026 | Täglich |
| VBR · VANGUARD INDEX FUNDS | 0,13% | 2.363.019 SH | 19. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,08% | 3.722.357 SH | 19. August 2026 | Täglich |
| ESML · iShares Trust | 0,07% | 59.663 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,07% | 1.958.933 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,07% | 368.585 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,07% | 58.328 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,04% | 8.633 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 31.254 SH | 2. Oktober 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 7.426 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 5.158.077 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 133.924 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 13.697 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,01% | 36.815 SH | 19. August 2026 | Täglich |
| ITOT · iShares Trust | 0,01% | 228.048 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 44.772 SH | 10. September 2026 | Täglich |
| ISCB · iShares Trust | · | 6.956 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 19.041 SH | 11. September 2026 | Täglich |
COGT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 18 Analysten
KAUF
Median-Ziel
$55.00
+79,4%
8 44,4%
Starker Kauf
8 44,4%
Kauf
2 11,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
11 Analysten · 2026-10-04Mittelwert-Ziel $55.82 +82,1%
← Unter allen Zielen
Aktueller Preis $30.66
Tief$45.00
Mittelwert$55.82
Hoch$62.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
| ORKA | $1.48B | -3.3 | · | · | -25.9% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 10, 2026